STOCK TITAN

RIV CAP INC - CNPOF STOCK NEWS

Welcome to our dedicated page for RIV CAP news (Ticker: CNPOF), a resource for investors and traders seeking the latest updates and insights on RIV CAP stock.

RIV Capital Inc. (CNPOF) is an acquisition and investment firm focused on building a leading multistate platform with a strong portfolio of cannabis brands in key U.S. markets. With in-house expertise, RIV Capital aims to grow its brands and partner with established operators, such as Etain, to expand market share and introduce new brands.

The company recently announced the opening of Etain's first co-located adult-use and medical dispensary in White Plains, NY. The acquisition of Etain and its strategic relationship with The Hawthorne Collective positions RIV Capital to capitalize on the growing U.S. cannabis market.

Rhea-AI Summary

RIV Capital has entered a settlement with JW Asset Management (JWAM), leading to the dismissal of an application related to its acquisition of Etain, LLC. The agreement involves RIV repurchasing 33,733,334 shares from JWAM for $19,625,000 and reimbursing $375,000 in legal fees. This settlement cancels JWAM's requisition for a special shareholder meeting scheduled for June 6, 2023. RIV Capital believes the share repurchase is in the best interest of the company, mitigating risks from the application and allowing focus on operational growth in New York and beyond. The company aims to build a multistate platform with a strong cannabis brand portfolio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.95%
Tags
none
-
Rhea-AI Summary

RIV Capital Inc. (CSE: RIV, OTC: CNPOF) is scheduled to report its third-quarter financial results for the period ending December 31, 2022, on March 1, 2023, before market opening. Investors can access the unaudited condensed interim consolidated financial statements and management analysis on SEDAR and RIV Capital's website. The company focuses on building a multistate cannabis platform with a strong brand portfolio in the U.S. markets, highlighted by its acquisition of Etain and partnerships with established operators. The release will be followed by an audio recording of the conference call available on the company’s site.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
-
Rhea-AI Summary

RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) has scheduled a Special Meeting of shareholders on June 6, 2023, at 10:00 a.m. EDT, in response to a requisition from JW Asset Management for the election of five new directors. The record date for voting eligibility is set for May 3, 2023. Shareholders are not required to take any action now, and a management proxy circular will be provided as per legal requirements. RIV Capital aims to strengthen its brand portfolio in key U.S. markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.81%
Tags
none
Rhea-AI Summary

RIV Capital Inc. announced that its board received a requisition from shareholders, primarily funds managed by JW Asset Management, on December 20, 2022. The requisition aims to call a special meeting to elect five new directors, following the recent election of seven nominees just three months earlier. JWAM controls over 5% of RIV Capital's shares and has previously sought a court order for the repurchase of shares held by its funds. The company is currently reviewing this requisition and advises shareholders to take no action for now.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.65%
Tags
none
-
Rhea-AI Summary

RIV Capital has finalized its acquisition of Etain, a vertically integrated cannabis operator in New York, for a total of US$42 million in cash and 5.27 million Class A common shares. This transaction secures RIV Capital a strategic foothold in the New York cannabis market with four dispensaries and a cultivation facility. The expansion of Etain's Chestertown facility is expected to be completed by Q2 2023, enhancing cultivation capacity and supporting new product formats in anticipation of adult-use sales. The transaction positions RIV Capital for future growth in a rapidly evolving market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.73%
Tags
none
-
Rhea-AI Summary

RIV Capital has received regulatory approvals to finalize the Etain Acquisition, expected by year-end 2022. The company holds $165 million cash to support this acquisition and expand Etain's facilities. However, RIV reported a significant net loss of $142.3 million for FQ2 2023, primarily due to a goodwill impairment charge of $138.9 million. Despite operational challenges in New York's cannabis market, RIV remains optimistic about future growth, focusing on social equity and developing its brand strategy. The company aims to enhance its cultivation capacity by 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
Rhea-AI Summary

RIV Capital Inc. (CSE: RIV, OTC: CNPOF) has announced that it will report its financial results for the second quarter ended September 30, 2022, on November 29, 2022. The unaudited financial statements and management discussion will be available on SEDAR and the company's website. RIV Capital is focused on building a strong portfolio of cannabis brands across key U.S. markets, supported by strategic partnerships, including a relationship with The Hawthorne Collective. Investors are advised that forward-looking statements may involve risks that could impact future results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
-
Rhea-AI Summary

RIV Capital Inc. congratulated Kathy Hochul on her reelection as New York's governor, expressing confidence in her commitment to establish a robust cannabis market. The company anticipates that the transition to an adult-use cannabis market will provide significant benefits, including job creation and tax revenue. RIV Capital aims to collaborate with the state to address challenges posed by unlicensed markets and support social equity within the cannabis sector. The firm looks forward to contributing to the growth of New York's cannabis industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.69%
Tags
none
-
Rhea-AI Summary

RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) announced the results of its Annual General Meeting held on September 29, 2022. Shareholders approved the election of all seven director nominees and the appointment of MNP LLP as auditors. RIV Capital aims to build a leading cannabis brand portfolio across key U.S. markets, supported by the acquisition of Etain and partnerships with established operators. The company is positioned as The Hawthorne Collective's preferred vehicle for cannabis investments outside its other subsidiaries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.34%
Tags
none

FAQ

What is the current stock price of RIV CAP (CNPOF)?

The current stock price of RIV CAP (CNPOF) is $0.08 as of December 19, 2024.

What is the market cap of RIV CAP (CNPOF)?

The market cap of RIV CAP (CNPOF) is approximately 14.7M.

What does RIV Capital Inc. focus on?

RIV Capital is an acquisition and investment firm that focuses on building a leading multistate platform with a strong portfolio of cannabis brands in key U.S. markets.

What recent announcement did RIV Capital make?

RIV Capital announced the opening of Etain's first co-located adult-use and medical dispensary in White Plains, NY.

How does RIV Capital plan to grow its brands?

RIV Capital aims to grow its brands by partnering with established U.S. cannabis operators and expanding market share.

What strategic relationship does RIV Capital have?

RIV Capital has a strategic relationship with The Hawthorne Collective, positioning it to capitalize on the growing U.S. cannabis market.

What sets RIV Capital apart in the cannabis industry?

RIV Capital's in-house expertise and partnerships with leading operators like Etain give it a competitive edge in the cannabis market.

What recent market developments has RIV Capital responded to?

RIV Capital has responded to positive changes in the tax structure for cannabis operators in New York and the potential rescheduling of cannabis under the Controlled Substances Act.

RIV CAP INC

OTC:CNPOF

CNPOF Rankings

CNPOF Stock Data

14.74M
113.88M
19.32%
30.32%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto